A detailed history of Core Wealth Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Core Wealth Partners LLC holds 545 shares of LLY stock, worth $424,347. This represents 0.29% of its overall portfolio holdings.

Number of Shares
545
Previous 337 61.72%
Holding current value
$424,347
Previous $305 Million 58.25%
% of portfolio
0.29%
Previous 0.21%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$772.14 - $960.02 $160,605 - $199,684
208 Added 61.72%
545 $483 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $50,740 - $63,632
70 Added 26.22%
337 $305 Million
Q1 2024

Apr 19, 2024

BUY
$592.2 - $792.28 $158,117 - $211,538
267 New
267 $208 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Core Wealth Partners LLC Portfolio

Follow Core Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Wealth Partners LLC with notifications on news.